New triple-action diabetes injection shows promise in reducing blood sugar and body weight
Science & Health

New triple-action diabetes injection shows promise in reducing blood sugar and body weight

7 Jun 2026 · Originally published 7 Jun 2026 9/10 Original headline: Triple-action diabetes jab shown to reduce blood sugar and body weight
A phase 3 trial has found that a weekly injection called retatrutide helps manage type 2 diabetes by mimicking three gut hormones to control appetite, blood sugar, and metabolism. Participants saw significant improvements in weight loss and blood sugar levels compared to a placebo, offering a new potential treatment option for those managing the condition.
Source: The Guardian UK National
Read the full story

About the AI positivity score

Report this article

Get your regular dose of good news

Follow the best stories on Bluesky or subscribe with your favourite feed reader.

How AI positivity scores work

Scores out of ten are AI estimates of how uplifting a story is, not a measure of accuracy or importance. Different readers may feel differently. Headlines and summaries are AI-written; follow the source link for the original reporting.

How stories are selected